📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nanopharm

1.1 - Company Overview

Nanopharm Logo

Nanopharm

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of science-driven orally inhaled and nasal drug product design and development services.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nanopharm

Synteract HCR Logo

Synteract HCR

HQ: United States Website
  • Description: Provider of global full-service contract research organization support for biotechnology, medical device, and pharmaceutical companies across all phases of clinical development, delivering customized Phase I–IV services collaboratively and cost effectively.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synteract HCR company profile →
VaLogic Logo

VaLogic

HQ: United States Website
  • Description: Provider of facility management solutions for pharma, biotech, and life sciences, delivering GxP compliance services (calibration, commissioning, qualification, validation, environmental monitoring), CQV, GMP environmental monitoring (air, surface, water, lab gases), cleanroom and biosafety cabinet certification, comprehensive calibration, and the LogiPoint continuous monitoring system for critical environments and equipment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VaLogic company profile →
LSL Pharma Logo

LSL Pharma

HQ: Canada Website
  • Description: Provider of life sciences manufacturing, offering turnkey formulation, development and manufacturing of sterile pharmaceutical products (including ointments) for hospitals, pharmacies and the animal health sector, and natural health products (including solid tablets).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LSL Pharma company profile →
Apex Innovative Sciences Logo

Apex Innovative Sciences

HQ: United States Website
  • Description: Provider of independent clinical trial site operations focused on central nervous system indications and other therapeutic areas, including neurology, psychiatry, and addiction, delivering high scientific and clinical quality for client partners and participants.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apex Innovative Sciences company profile →
Par Excellence Logo

Par Excellence

HQ: United States Website
  • Description: Provider of inventory management systems for the healthcare sector, offering innovative, affordable point-of-use solutions that assist materials management professionals, utilizing state-of-the-art technologies and over twenty years of innovation to meet dynamic requirements.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Par Excellence company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nanopharm

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nanopharm

2.2 - Growth funds investing in similar companies to Nanopharm

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nanopharm

4.2 - Public trading comparable groups for Nanopharm

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nanopharm

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nanopharm

What does Nanopharm do?

Nanopharm is a provider of science-driven orally inhaled and nasal drug product design and development services.

Who are Nanopharm's competitors?

Nanopharm's competitors and similar companies include Synteract HCR, VaLogic, LSL Pharma, Apex Innovative Sciences, and Par Excellence.

Where is Nanopharm headquartered?

Nanopharm is headquartered in United Kingdom.

How many employees does Nanopharm have?

Nanopharm has 1,000 employees 🔒.

When was Nanopharm founded?

Nanopharm was founded in 2010 🔒.

What sector and industry vertical is Nanopharm in?

Nanopharm is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nanopharm

Who are the top strategic acquirers in Nanopharm's sector and industry

Top strategic M&A buyers and acquirers in Nanopharm's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nanopharm?

Top strategic M&A buyers groups and sectors for Nanopharm include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nanopharm's sector and industry vertical

Which are the top PE firms investing in Nanopharm's sector and industry vertical?

Top PE firms investing in Nanopharm's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nanopharm's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nanopharm's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nanopharm's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nanopharm include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nanopharm's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nanopharm?

The key public trading comparables and valuation benchmarks for Nanopharm include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nanopharm for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nanopharm with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nanopharm's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nanopharm with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nanopharm's' sector and industry vertical?

Access recent funding rounds and capital raises in Nanopharm's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nanopharm